The Biotech Growth Trust PLC
1 October 2014
The Biotech Growth Trust PLC (the'Company')
Listing Rule 15.5.1 (4) - Transactions in a Close Period
In accordance with Listing Rule 15.5.1 (4), the Directors of the Company
confirm that they are satisfied that all inside information that the Directors
and the Company have up until the date of this notice has been notified to a
Regulated Information Service ("RIS") and that any further inside information
leading up to the announcement of the half year results for the six months to
30 September 2014 will be notified to a RIS.
The Company and persons discharging managerial responsibilities for the Company
are therefore exempt during the close period from the provisions of the Model
Code in respect of dealings in the Company's own securities. If, in the period
leading up to the announcement of the half year results, the Directors of the
Company or any person discharging managerial responsibilities come into
possession of any inside information, this will be notified to a RIS before any
such transactions are undertaken.
The close period to which this notification relates is in respect of the six
months ended 30 September 2014.
Frostrow Capital LLP
Company Secretary
1 October 2014
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.